Apr 13 Blood clots after Johnson & Johnson COVID-19 vaccine are ‘extremely rare,’ experts say By Laura Santhanam The six women who reported blood clots were between ages 18 and 48 and had received the Johnson & Johnson vaccine between six and 13 days before reporting side effects. So far, 6.8 million doses of this one-shot vaccine have… Continue reading
Apr 13 WATCH: What to know about the Johnson & Johnson vaccine pause By Laura Santhanam, Amna Nawaz What does the move mean for those who have received the one dose vaccine and how will it affect the U.S. vaccination rollout?… Continue reading
Apr 13 WATCH: FDA, CDC experts answer questions about pause on Johnson & Johnson vaccine By Associated Press The nation's leading infectious-diseases expert says "safety is the important issue here" when discussing the "pause" in the use of the Johnson & Johnson vaccine. Continue reading
Apr 13 U.S. recommends ‘pause’ for J&J vaccine over clot reports By Zeke Miller, Associated Press The U.S. is recommending a "pause" in administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots. Continue reading
Apr 01 Company at heart of Johnson & Johnson vaccine woes has series of citations By Richard Lardner, Linda A. Johnson, Associated Press The company at the center of quality problems that led Johnson & Johnson to discard a batch of its coronavirus vaccine has a string of citations from U.S. health officials for quality control problems. Continue reading
Mar 10 WATCH: Biden meets with CEOs of Johnson & Johnson about COVID-19 vaccine By Associated Press The nation’s top infectious disease expert says the U.S. could see significant steps toward a return to the pre-pandemic normal, even before the country reaches coronavirus herd immunity. Continue reading
Mar 05 Canada approves Johnson & Johnson vaccine By Rob Gillies, Associated Press Canada is getting a fourth vaccine to prevent COVID-19 as the country’s health regulator has cleared a Johnson & Johnson shot that works with just one dose instead of two. Continue reading
Mar 02 U.S. will be able to vaccinate all adults by end of May, Biden says By Zeke Miller, Linda A. Johnson, Associated Press Drugmaker Merck & Co. will help produce rival Johnson & Johnson's newly approved coronavirus vaccine in an effort to expand supply more quickly. Continue reading
Mar 01 States easing COVID-19 restrictions despite experts’ warnings By Heather Hollingsworth, Tammy Webber, Associated Press The head of the Centers for Disease Control and Prevention is urgently warning state officials and ordinary Americans not to let their guard down. Continue reading
Feb 27 J&J’s 1-dose shot cleared, giving US 3rd COVID-19 vaccine By Lauran Neergaard, Matthew Perrone, Associated Press The FDA said J&J’s vaccine offers strong protection against what matters most: serious illness, hospitalizations and death. One dose was 85% protective against the most severe COVID-19 illness, in a massive study that spanned three continents — protection that remained… Continue reading